Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF (2018) Antithrombotic therapy and body mass: an expert position paper of the ESC working group on thrombosis
That misbalance should be addressed in future research
We apologize for any inconvenience this may cause
Roche is positioning it as a gentler alternative for those who cannot tolerate the nausea often associated with some GLP-1 drugs
When these nerves are damaged, the signals become garbled
Cardiovasc Diabetol 17(1):83 European Medicines Agency (EMA) (2012) Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus European Medicines Agency (EMA) (2016) Reflection paper on assessment of cardiovascular safety profile of medicinal products Farah LX, Valentini V, Pessoa TD, Malnic G, McDonough AA, Girardi AC (2016) The physiological role of glucagon-like peptide-1 in the regulation of renal function
